Abstract:Polyethylene glycol (PEG) is widely used polymer in the field of pharmaceutics, particularly in which related to drug delivery systems (DDS). Surface coating of the nanoparticles (NPs) with PEG (i.e. pegylation) adds novel characteristics that make their use in vivo more effective with lower cytotoxicity. The biodistribution profiles, reaction, and fate of PEG-coated NPs in vivo still unclear and need more detailed studies. Here in this study, we prepared PEG-coated iron oxide nanoclusters (PEG-coated IONCs) to investigate their biodistribution profiles and reactions in spleen after intravenous injection time-dependently. Using Prussian blue staining method as specific histochemical reaction for iron detection in the tissues, the PEG-coated IONCs were observed in a higher ratio in spleen red pulp after 1 day of injection but decreased time-dependently after 10 days and 20 days. Interestingly, PEG-coated IONCs moved from red pulp into the white pulp specially after 20 days of injection. After long time exposure (20 days), higher amount of PEG-coated IONCs was observed in the center of spleen white pulp follicle. Using histological staining, the reaction of PEG-coated IONCs with splenocytes or immune cells induced cellular abnormalities such as, nucleic acid damages, induction of megakaryocytes number, and sever vacuolation in the white pulp area specially after 20 days of injection. Histochemically, the localization of PEG-coated IONCs in the splenic parenchyma induced the level of the collagen fibers particularly after 1 day and 10 days of injection. Interestingly, cellular abnormalities in the splenic red pulp as well as collagen levels decreased after 20 days of injection due to the clearance of PEG-coated IONCs from this area. This data indicated that cytotoxicity produced by the reaction of PEG-coated IONCs in the spleen are reversible specially after 20 days of in the intravenous injection. Understanding the detailed mechanism of the fate and reaction of the coated nanomaterials after intravenous injection is important to design effective and safe DDS based NPs.

Systemic Toxicity and Toxicokinetics of a High Dose of Polyethylene Glycol 400 in Dogs Following Intravenous Injection

A cautionary note: Toxicity of polyethylene glycol 200 injected intraperitoneally into mice

Polyethylene Glycol 4000 Treatment for Children with Constipation: A Randomized Comparative Multicenter Study

Toxicity of glufosfamide in Beagle dogs following intravenous injection

Time-dependent biodistribution profiles and reaction of polyethylene glycol-coated iron oxide nanoclusters in the spleen after intravenous injection in the mice

Long-term toxicity test of ethyl pyruvate injection in rats

Subchronic Toxicity and Immunotoxicity of MeO-PEG-poly(D,L-lactic-co-glycolic Acid)-Peg-ome Triblock Copolymer Nanoparticles Delivered Intravenously into Rats.

Pharmacokinetics of Polyethylene Glycol-Modified Canine Uricase Following Single and Multiple Intravenous Injections in Cynomolgus Monkeys

Effects of diethylene glycol in different administration manners on renal function in rats

Thirteen-week Veinal Toxicity Study of Ginkgolides Sodium Chloride Injection in Beagle Dogs

Clinical Impact of Antipolyethylene Glycol (PEG) Antibody in Hematological Patients Administered PEGylated-Granulocyte Colony-Stimulating Factor

Toxicity of a Novel Anti-Tumor Agent 20(S)-Ginsenoside Rg3: A 26-Week Intramuscular Repeated Administration Study in Beagle Dogs

Accelerated Blood Clearance of Pegylated Liposomal Topotecan: Influence of Polyethylene Glycol Grafting Density and Animal Species.

Detrimental Impacts of Pharmaceutical Excipient PEG400 on Gut Microbiota and Metabolome in Healthy Mice

Short-term Urea Cycle Inhibition in Rat Liver Cells Induced by Polyethylene Glycol

Toxicity Study of 28-Day Subcutaneous Injection of Arctigenin in Beagle Dogs

Genotoxicity and subchronic toxicological study of a novel ginsenoside derivative 25-OCH 3 -PPD in beagle dogs

Acute toxicity evaluation of in situ gel-forming controlled drug delivery system based on biodegradable poly(ε-caprolactone)-poly(ethylene glycol)-poly(ε-caprolactone) copolymer

Pharmacokinetics of Glutathione and the Component Amino Acids by Gavage and iv in Beagle Dogs

A Multiple-Dose Pharmacokinetics of Polyethylene Glycol Recombinant Human Interleukin-6 (Peg-Rhil-6) in Rats

Investigation of Toxicological Effects of Shuanghuanglian Injection in Beagle Dogs by Metabonomic and Traditional Approaches